DR. RECKEWEG R9 Jutussin

Product NDC: 53346-1309
11-digit product format: 533461309
Labeler code: 53346
Product ID: 53346-1309_e7745d5c-f957-45e3-a9a9-35c4576e027b
Type: HUMAN OTC DRUG
Nonproprietary name: Belladonna 4X, Bryonia 4X, Coccus cacti 6X, Corallium rubrum 12X, Cuprum aceticum 12X, Drosera 4X, Ipecacuanha 6X, Spongia tosta 6X, Sticta pulmonaria 4X
Dosage form: LIQUID
Route: ORAL
Labeler: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 1986-06-01
Marketing end: 0000-00-00
Substance: ATROPA BELLADONNA; BRYONIA DIOICA ROOT; PROTORTONIA CACTI; CORALLIUM RUBRUM EXOSKELETON; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA; IPECAC; SPONGIA OFFICINALIS SKELETON, ROASTED; LOBARIA PULMONARIA
Active strength: 4 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53346-1309		I	Inactivated by FDA		2026-10-05
excluded package	package	53346-1309	53346-1309-5	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53346-1309-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53346-1309-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53346-1309-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53346-1309-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53346-1309-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53346-1309-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53346-1309-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53346-1309-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53346-1309-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53346-1309-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53346-1309-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53346-1309-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53346-1309-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53346-1309-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53346-1309-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53346-1309-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53346-1309-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53346-1309-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53346-1309-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53346-1309-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53346-1309-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53346-1309-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0306390c-dd77-4363-afe0-63c58088b2a1	Product name	1	20220120
503ea967-4b9c-48cf-9e87-c7975295849d	Product name	2	20220120

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53346-1309-5	2020-01-31	C162847	48780-1	9d75b9d0-2f83-f424-e053-dadaa90a57ce	DR. RECKEWEG R9 Jutussin

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53346-1309-5	DR. RECKEWEG R9 JutussinCombination Product	50 mL in 1 BOTTLE	LIQUID	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
BRYONIA DIOICA ROOT	ACTIVE INGREDIENT	53UB5FH7CX	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CORALLIUM RUBRUM EXOSKELETON	ACTIVE INGREDIENT	2CA71K0DLE	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CUPRIC ACETATE	ACTIVE INGREDIENT	39M11XPH03	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DROSERA ROTUNDIFOLIA	ACTIVE INGREDIENT	QR44N9XPJQ	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
IPECAC	ACTIVE INGREDIENT	62I3C8233L	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LOBARIA PULMONARIA	ACTIVE INGREDIENT	D1YM0P5Z2T	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
PROTORTONIA CACTI	ACTIVE INGREDIENT	LZB7TFX1LT	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SPONGIA OFFICINALIS SKELETON, ROASTED	ACTIVE INGREDIENT	1PIP394IID	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
BRYONIA CRETICA SUBSP. DIOICA ROOT	ACTIVE MOIETY	53UB5FH7CX	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CORALLIUM RUBRUM EXOSKELETON	ACTIVE MOIETY	2CA71K0DLE	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CUPRIC CATION	ACTIVE MOIETY	8CBV67279L	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DROSERA ROTUNDIFOLIA	ACTIVE MOIETY	QR44N9XPJQ	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
IPECAC	ACTIVE MOIETY	62I3C8233L	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
LOBARIA PULMONARIA	ACTIVE MOIETY	D1YM0P5Z2T	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
PROTORTONIA CACTI	ACTIVE MOIETY	LZB7TFX1LT	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SPONGIA OFFICINALIS SKELETON, ROASTED	ACTIVE MOIETY	1PIP394IID	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53346-1309	DR. RECKEWEG R9 JUTUSSIN COMBINATION PRODUCT (BELLADONNA 4X, BRYONIA 4X, COCCUS CACTI 6X, CORALLIUM RUBRUM 12X, CUPRUM ACETICUM 12X, DROSERA 4X, IPECACUANHA 6X, SPONGIA TOSTA 6X, STICTA PULMONARIA 4X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1	Legacy NDC, 1 package rows	20130514_f47f81dd-3cb3-4d47-9447-cd5c1ad4de45.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WQZ3G9PF0H	ATROPA BELLADONNA		ATROPA BELLADONNA
53UB5FH7CX	BRYONIA DIOICA ROOT		BRYONIA DIOICA ROOT
LZB7TFX1LT	PROTORTONIA CACTI		PROTORTONIA CACTI
2CA71K0DLE	CORALLIUM RUBRUM EXOSKELETON		CORALLIUM RUBRUM EXOSKELETON
39M11XPH03	CUPRIC ACETATE	142-71-2	CUPRIC ACETATE
QR44N9XPJQ	DROSERA ROTUNDIFOLIA		DROSERA ROTUNDIFOLIA
62I3C8233L	IPECAC	8012-96-2	IPECAC
1PIP394IID	SPONGIA OFFICINALIS SKELETON, ROASTED		SPONGIA OFFICINALIS SKELETON, ROASTED
D1YM0P5Z2T	LOBARIA PULMONARIA		LOBARIA PULMONARIA

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
53346-1309-5	53346130905	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DR. RECKEWEG R9 Jutussin	PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO	2013-04-03	HUMAN OTC DRUG LABEL	1